A Response Letter by Cameron et al-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Response Letter by Cameron et al

Published:2024-08 Issue:8 Volume:19 Page:e26-e28
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Cameron Robert B.^ORCID,Hines Jacobi B.,Torri Valter,Garassino Marina C.

Funder

NIGMS

Publisher

Elsevier BV

Reference5 articles.

1. Neoadjuvant chemo-immunotherapy for early-stage non-small cell lung cancer: a systematic review and meta-analysis;Banna;JAMA Netw Open,2024

2. Evaluation of major pathologic response and pathologic complete response as surrogate end points for survival in randomized controlled trials of neoadjuvant immune checkpoint blockade in resectable in NSCLC;Hines;J Thorac Oncol,2024

3. Impacts of additional cycles of neoadjuvant immunotherapy on surgery in non-small-cell lung cancer;Chen;Thorac Cancer,2023

4. Zhu D, Huang Z, Xiao K, et al. Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non-small cell lung cancer in locally advanced stage? Retrospective experience based on a single center [e-pub ahead of print]. Asia Pac J Clin Oncol. https://doi.org/10.1111/ajco.13971. Accessed June 1, 2024.

5. Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes: a real-world analysis;Zhang;Front Oncol,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP